chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Myalgia, Paraesthesia
Clinical narrative: right hand finger tingling; Headache, Right sided.; body muscle aches; overall feeling of being sick; This is a spontaneous report from a contactable other healthcare professional.   A 52-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Right on 25Feb2021 09:00 am (at the age of 51-year-old) as dose 2, single for covid-19 immunisation. Medical history included high cholesterol, heart disease, diabetes from an unknown date and unknown if ongoing. Concomitant medications included atorvastatin calcium (LIPITOR) taken for an unspecified indication, start and stop date were not reported; carvedilol (COREG) taken for an unspecified indication, start and stop date were not reported; olmesartan medoxomil (BENICAR) taken for an unspecified indication, start and stop date were not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Right on 04Feb2021 09:00 am (at the age of 51-year-old) as dose 1, single for covid-19 immunisation. On 25Feb2021 16:00, the patient experienced right hand finger tingling, headache, right sided, body muscle aches, overall feeling of being sick. No treatment was taken as a result of events. The outcome of the events were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Tingling in my right arm, going down to right arm and then it was all down to my right side of my body to the bottom of my foot; Had tingling and numbness for entire 9 days after the shot; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EM9809, the consumer stated that, there was no expiration date of Pfizer COVID-19 Vaccine), via an unspecified route of administration on 14Feb2021 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. The patient medical history included diabetes. Concomitant medications included hydrochlorothiazide, dulaglutide (TRULICITY), hydralazine, metoprolol, atorvastatin, insulin detemir (LEVEMIR). The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3248), via an unspecified route of administration on 24Jan2021 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. She called because she knows they said they can put this form online but since she had this problem for about 9 days now. She just wanted to talk to someone. Stated that, she received her second shot on 14Feb2021. Stated that, she was going to say about an hour after her shot she started feeling some tingling in her right arm, going down to right arm and then it was all down to her right side of her body to the bottom of her foot. Stated that, she don't think it was because of the fact that sometimes they said your arm would be a problem where you got your injection, but the patient wanted to say that she had tingling and numbness for entire 9 days after the shot. The patient did not received treatment for the events and stated that, she didn't know what it was. When provided with the number Pfizer Medical Information, consumer stated that, she had been through doctor one time. They don't know very much about it. She had an appointment again for tomorrow. Stated that, she like to provide as much information as possible so she can get over her problem with her right side. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure measurement, Dizziness, Electrocardiogram, Headache
Clinical narrative: Tachycardia; tingly; dizzy/lightheaded; weak; nauseated; my heart was pounding; high blood pressure; I have had a very bad headache; This is a spontaneous report from a contactable consumer or other non health care professional. A 65-years-old non-pregnant female received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot no: EN6202, Expiry date not reported), via unspecified route of administration in left arm on 26Feb2021 at 02:15 (at age of 65-years-old) as dose 1, single for COVID-19 Immunization. Patient medical history includes chronic fatigue, migraines, tetanus vaccine (fever and sick), epinephrine (same reaction as the covid: vaccine: tachy, high BP, lightheaded, weakness, nausea for several hours; took me a few days to normalize), hypertension. Patient concomitant medications include metoprolol, flecainide, orphenadrine, fenofibrate used for unspecified indication from unknown date and unknown ongoing. Prior vaccination patient was not tested for COVID. Post vaccination patient was not tested for COVID. On 26Feb2021 at 14:30 (within 15 mins of vaccination), patient experienced tingly, dizzy, lightheaded, weak, nauseated, and her heart was pounding. Patient also experienced tachycardia and high blood pressure (184\116). That evening and the next 2 days patient had a very bad headache, weakness, dizziness, some nausea. Patient stated she is better, but still some headache, nausea, weakness. Patient had to visit emergency room due to events. Patient received treatment for events. The patient underwent lab test and procedure include blood pressure measurement was 184/116 and Electrocardiogram result was unknown on unspecified date. Facility type vaccine: Doctor's office/urgent care. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Nausea, Palpitations, Paraesthesia, Tachycardia
Clinical narrative: Tachycardia; tingly; dizzy/lightheaded; weak; nauseated; my heart was pounding; high blood pressure; I have had a very bad headache; This is a spontaneous report from a contactable consumer or other non health care professional. A 65-years-old non-pregnant female received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot no: EN6202, Expiry date not reported), via unspecified route of administration in left arm on 26Feb2021 at 02:15 (at age of 65-years-old) as dose 1, single for COVID-19 Immunization. Patient medical history includes chronic fatigue, migraines, tetanus vaccine (fever and sick), epinephrine (same reaction as the covid: vaccine: tachy, high BP, lightheaded, weakness, nausea for several hours; took me a few days to normalize), hypertension. Patient concomitant medications include metoprolol, flecainide, orphenadrine, fenofibrate used for unspecified indication from unknown date and unknown ongoing. Prior vaccination patient was not tested for COVID. Post vaccination patient was not tested for COVID. On 26Feb2021 at 14:30 (within 15 mins of vaccination), patient experienced tingly, dizzy, lightheaded, weak, nauseated, and her heart was pounding. Patient also experienced tachycardia and high blood pressure (184\116). That evening and the next 2 days patient had a very bad headache, weakness, dizziness, some nausea. Patient stated she is better, but still some headache, nausea, weakness. Patient had to visit emergency room due to events. Patient received treatment for events. The patient underwent lab test and procedure include blood pressure measurement was 184/116 and Electrocardiogram result was unknown on unspecified date. Facility type vaccine: Doctor's office/urgent care. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Mood altered, Paraesthesia
Clinical narrative: Pins and needles; Very upset; This is a spontaneous report from a contactable other HCP (patient herself). A 71-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution injection; Batch/Lot number unknown), via an unspecified route of administration, administered in Arm Left on Jan2021 at 12 AM (age at 71-year-old ) as single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medications were not reported as no. The patient have no known drug allergies. Patient received other pfizer vaccine in left arm on 05Jan2021. The patient did not have any other vaccine in four weeks. The patient did not have any other medications in two weeks. The patient did not have COVID prior to vaccination. On 02Feb2021, she experienced very bad reaction to Pfizer. She had pins and needles which she had it for one month. She was very upset. She reported that she still have pins and needles. adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.Therapeutic measures were taken in response to the events. She was not tested for covid post vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Pruritus, Urticaria
Clinical narrative: With the itching and hives, this started within a couple hours of getting the shot. It was also with first dose but she thought it was dry skin; it also started within a few hours of first dose; With the itching and hives, this started within a couple hours of getting the shot. It was also with first dose but she thought it was dry skin; it also started within a few hours of first dose; With the itching and hives, this started within a couple hours of getting the shot. It was also with first dose but she thought it was dry skin; it also started within a few hours of first dose; This is a spontaneous report from a contactable consumer (patient herself). A 52-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date not reported, age at the time of vaccination: 52-year-old), via an unspecified route of administration, in Hand Right (shoulder) on an unknown date in Jan2021 and was given around 14:30 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date in Jan2021, the patient experienced itching and hives, which started within a few hours of getting the first shot but she thought it was dry skin. The outcome of events was unknown.  Follow-up attempts completed. No further information expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: I had a strong off-cycle menstrual period 2 weeks after my first dose. /I had a full menstrual cycle 14 days; This is a spontaneous report received from a contactable consumer (Patient). A 47-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date: Not reported), via an unspecified route of administration, administered in left arm on 25Feb2021 at 09:00 (at the age of 47-year-old) as dose 1, single for COVID-19 immunization at Doctor's office/urgent care. The patient had various other medical history, none related to hormones or menstrual cycle and had no known allergies. Patient concomitant medications were not reported. Prior to vaccination, the patient did not receive any other vaccines within 4 weeks and was not diagnosed with COVID-19. On an unspecified date in 2021, patient had a strong off-cycle menstrual period 2 weeks after her first dose. Even though she was 47 years old, she has a period every 26 days for years. This month, she had a full menstrual cycle 14 days after her last period which also happens to have been 14 days after first dose. No treatment was received to treat adverse event. Since the vaccination, the patient has not been tested for COVID-19. The event was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure fluctuation, Blood pressure measurement, Computerised tomogram, Electrocardiogram, Head discomfort
Clinical narrative: got explosive feeling headache suddenly /debilitating headache/ chronic headache; Migraine headache; Blood pressure still up and down; lots of pressure in head; Hypertension; This is a spontaneous report from a contactable other hcp. A 68-year-old female patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 05Feb2021 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. Concomitant medication(s) included estrogens conjugated (PREMARIN). Covid prior vaccination Yes. The patient previously took emycin [erythromycin] and experienced drug hypersensitivity, codeine and experienced drug hypersensitivity, None other medical history. Historical vaccine includes bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 1 for covid-19 immunization. Covid not tested post vaccination. On 28Feb2021 09:45 the patient experienced got explosive feeling headache suddenly /debilitating headache/ chronic headache since then. Seen by doctor on Fri 05Mar2021, diagnosed HTN (hypertension) she never had HNT. Seen Emergency room on Monday 3-8 due to debilitating headache. Told Migraine headache with HTN. Started Medrol Dose pack 3-9. B/P still up and down and headaches no longer debilitating but chronically top of scalp left side/ lots of pressure in head. On an unspecified date the patient underwent lab tests which included blood pressure measurement result still up and down, computerised tomogram result normal, electrocardiogram result normal, laboratory test result normal. Therapeutic measures were taken as a result of all the event's includes Lisinopril 10mg/ Medrol Dose 6 day pack. The outcome for all events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Laboratory test, Migraine
Clinical narrative: got explosive feeling headache suddenly /debilitating headache/ chronic headache; Migraine headache; Blood pressure still up and down; lots of pressure in head; Hypertension; This is a spontaneous report from a contactable other hcp. A 68-year-old female patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 05Feb2021 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. Concomitant medication(s) included estrogens conjugated (PREMARIN). Covid prior vaccination Yes. The patient previously took emycin [erythromycin] and experienced drug hypersensitivity, codeine and experienced drug hypersensitivity, None other medical history. Historical vaccine includes bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 1 for covid-19 immunization. Covid not tested post vaccination. On 28Feb2021 09:45 the patient experienced got explosive feeling headache suddenly /debilitating headache/ chronic headache since then. Seen by doctor on Fri 05Mar2021, diagnosed HTN (hypertension) she never had HNT. Seen Emergency room on Monday 3-8 due to debilitating headache. Told Migraine headache with HTN. Started Medrol Dose pack 3-9. B/P still up and down and headaches no longer debilitating but chronically top of scalp left side/ lots of pressure in head. On an unspecified date the patient underwent lab tests which included blood pressure measurement result still up and down, computerised tomogram result normal, electrocardiogram result normal, laboratory test result normal. Therapeutic measures were taken as a result of all the event's includes Lisinopril 10mg/ Medrol Dose 6 day pack. The outcome for all events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: I have not had my menstrual cycle since getting vaccinated; This is a spontaneous report from a contactable other HCP. A 30-year-old (Adult 18-64 years) non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left, on 23Feb2021 at 22:00 (at the age of 30 years), as single dose for covid-19 immunisation. The patient medical history included known allergies: Gluten from an unknown date and unknown if ongoing. Patient not diagnosed with covid-19 prior to vaccination. Patient was not received any other vaccine prior four weeks of vaccination and patient did not receive any medication prior two weeks of vaccination. Since vaccination patient not tested for covid-19. Patient reported I don't think you would call this an adverse side effect as its much more of an unexpected benefit or bonus. I have not had my mensural cycle since getting vaccinated on 23Feb2021 and I am absolutely thrilled with this. I am 100% not pregnant because that requires liking men. Honestly best thing I could ask for thank you so much If it discovered this is due to a certain compound or something in the shot I will gladly sign up for a clinical study. The outcome of the event was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: period arrived 5 days late after taking the vaccine. Patient had an extremely regular cycle and was never late. Now that it had arrived, it was not a normal flow (light). Late menstrual cycle.; This is a spontaneous report from a contactable consumer (the patient, reported for herself). A 36-year-old non-pregnant female received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; lot number and expiration date were not reported), via unspecified route of administration, in the right arm, on 07Mar2021 08:45 (at the age of 36-year-old), as unknown dose number, single, for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications was not reported. Patient did not receive other vaccine in four weeks and did not receive any other medications in two weeks. No COVID prior vaccination. The patient was not tested for COVID-19 since having the vaccine. On 09Mar2021, patient's period arrived 5 days late after taking the vaccine. Patient had an extremely regular cycle and was never late. Now that it had arrived, it was not a normal flow (light). Late menstrual cycle. Patient did not receive the any treatment for event. Outcome of the event was recovering.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Hypoaesthesia oral, Lip swelling, Pain in extremity
Clinical narrative: tingle in left hand; felt hot; her face was flushed; her lip started to swell with a little bit of redness above the right side of her lip; her arm was sore too; touched her lip and it felt numb; This is a spontaneous report from a contactable consumer or other non hcp. A 49-year-old female patient received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9266), via an unspecified route of administration in Arm Left on 07Mar2021 16:30 as dose 1, single for covid-19 immunisation (at hospital). patient didn't received other mediations within 4 weeks prior to vaccination patient didn't had any illness prior to vaccination. Medical history included food allergy shellfish allergy from an unknown date and unknown if ongoing. The concomitant medications were not reported. On 07Mar2021 the patient experienced tingle in left hand, felt hot, her face was flushed, her lip started to swell with a little bit of redness above the right side of her lip, her arm was sore too, touched her lip and it felt numb. Therapeutic measures were taken for the events Benadryl was prescribed by physician. She would be planning to receive her second dose on26MAR2021 No relevant tests were reported. The outcome of the events paraesthesia, feeling hot, flushing, lip swelling, pain in extremity, hypoaesthesia oral was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingle in left hand; felt hot; her face was flushed; her lip started to swell with a little bit of redness above the right side of her lip; her arm was sore too; touched her lip and it felt numb; This is a spontaneous report from a contactable consumer or other non hcp. A 49-year-old female patient received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9266), via an unspecified route of administration in Arm Left on 07Mar2021 16:30 as dose 1, single for covid-19 immunisation (at hospital). patient didn't received other mediations within 4 weeks prior to vaccination patient didn't had any illness prior to vaccination. Medical history included food allergy shellfish allergy from an unknown date and unknown if ongoing. The concomitant medications were not reported. On 07Mar2021 the patient experienced tingle in left hand, felt hot, her face was flushed, her lip started to swell with a little bit of redness above the right side of her lip, her arm was sore too, touched her lip and it felt numb. Therapeutic measures were taken for the events Benadryl was prescribed by physician. She would be planning to receive her second dose on26MAR2021 No relevant tests were reported. The outcome of the events paraesthesia, feeling hot, flushing, lip swelling, pain in extremity, hypoaesthesia oral was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness, Diarrhoea, Intermenstrual bleeding
Clinical narrative: Breast tenderness; Diarrhea; Break through bleeding; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 62-year-old female patient (age at vaccination 62-year) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: EN6207) via an unspecified route of administration (age at vaccination 62-year) in Left Arm on 15Mar2021 14:00 PM as dose 1, single for COVID-19 immunization. Medical history included nausea (had a little stomach nausea the day before); menopause (States that she has been menopausal for 15 years) from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. On 17Mar2021 the patient experienced break through bleeding and diarrhea; on 18Mar2021 the patient experienced breast tenderness. AE does not require to visit Emergency room/Physician office. The patient was calling about the COVID-19 vaccine. States that she had some strange symptoms after her 1st dose on Monday. States that she doesn't really like her primary care practice. They weren't offering the vaccine, and even their nurse wasn't going to take the vaccine, she said she was just going to wait and see how it played out. States that she has been menopausal for 15 years, and had break thorough bleeding for a day, and had breast tenderness for a day after receiving the vaccine. States she has never had that happen in 15 years. She also had crazy diarrhea for 12 hours; it was intense. List of other relevant diagnostic and confirmatory test results for event was not reported. The clinical outcome of the events "break through bleeding" was recovered on 17Mar2021, "diarrhea" was recovered on 18Mar2021, "breast tenderness" was recovered on 19Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Infection, Intermenstrual bleeding
Clinical narrative: menstrual bleeding; infection; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was: unknown), via an unspecified route of administration, administered in Arm Right on 23Jan2021 (at the age of vaccination 27-year-old) as single dose for COVID-19 immunization at Doctor or other healthcare professional office/clinic visit. Medical history included MHE (Minimal hepatic encephalopathy) and Known alleries Sulfa-containing drugs. Concomitant medications were not reported. patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications was not received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 Prior to vaccination and Since the vaccination patient was not tested for COVID-19. The patient experienced menstrual bleeding and infection on 24Jan2021. Reported as Started menstrual bleeding about 24 hrs after infection. I didn't think anything was abnormal at first, but I am still having bleeding 2 months later. I have never experienced prolonged menstrual bleeding before. My periods have always been no longer than 4 days in length, with some missed periods here and there. I have been to see my GP and no direct cause could be determined at this time. I looked back on the date I received my first dose of Pfizer vaccine and the saw a possible correlation between that date and the onset of my symptoms. After doing some research I ran across this article and I believe there may be a connection to what I'm experiencing. As of this time I was still bleeding. No treatment received for the adverse events. The outcome of the events was not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: it looked like what I've heard shingles looks like.  My urgent care clinic appt on 3/20/21 confirmed this suspicion; Eight days after getting my 1st Pfizer vaccine, i noticed a rash on my torso (3/19/21).  Tho i've never had it before, it looked like what I've heard shingles looks like.  My urgent care clinic appt o; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 67-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: en6206), via an unspecified route of administration (at the age of 67-years), administered in Arm Left on 11Mar2021 15:15 as dose 1, single for COVID-19 immunization. Medical history included known allergies from sulfa and Take meds named earlier for depression; that's all. Concomitant medications included venlafaxine, levothyroxine, cyanocobalamin (B-12) , aspirin [acetylsalicylic acid] (low-dose ASPIRIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took thimerosal and experienced known allergies. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not had Covid prior vaccination, and the test was not performed post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Mar2021 14:00, the patient stated that eight days after getting my 1st Pfizer vaccine, I noticed a rash on my torso (19Mar2021), though I had never had it before, it was looked like what I had heard shingles looks like. My urgent care clinic appt on 20Mar2021 confirmed this suspicion. I began taking Valacyclovir that afternoon/evening but could not tolerate it so, after a call to the urgent care clinic, I switched to Acyclovir, which I will be on till 31Mar2021. The treatment was received for the adverse event with valacyclovir and acyclovir. The adverse event result in Emergency room/department or urgent care. The facility most recent COVID-19 vaccine was administered in Pharmacy or Drug Store. The clinical outcome of the events was reported as recovering.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Migraine, Myalgia, Urticaria
Clinical narrative: Trouble breathing; Acute migraine; Hives; Muscular pain; This is a spontaneous report from a contactable consumer (patient). A 41-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9263) via an unspecified route of administration, in Arm Right on 26Feb2021 13:15 (at the age of 41 years old), as single for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. The patient did not receive other vaccine within four weeks of COVID vaccine and she did not take other medications within two weeks of vaccination. The patient did not have COVID prior to vaccination. The patient concomitant medications were not reported. On 28Feb2021 15:00, the patient experienced trouble breathing, acute migraine, hives, and muscular pain. These adverse events resulted in emergency room/department or urgent care visit. The patient received treatment with benadryl and pain medicine. The patient did not test for COVID post vaccination. The outcome of all the events were resolved, on an unspecified date in 2021.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: Body ache; Low grade fever; Head ache; This is spontaneous report from contactable consumer. A 53-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration on 24Mar2021 at 18:30, (at the age of 53 years old), as a single dose for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history and concomitant medication were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration, on 03Mar2021 at 19:15, (at the age of 53 years old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 25Mar2021 at 13:00, the patient experienced low grade fever, headache and body ache. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. No therapeutic measures were taken as a result of the events. The clinical outcome of fever, headache and body ache were recovered on an unknown date in Mar2021.   Information about lot/batch number cannot be obtained. No further information expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Headache, Lacrimation increased
Clinical narrative: itchy eyes; watery eyes; frontal headache; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207), via an unspecified route of administration in the left arm on 19Mar2021 at 12:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL266), via an unspecified route of administration in left arm on 26Feb2021 at 13:00 (at the age of 67 years old) as a single dose for COVID-19 immunisation. Medical history included insulin resistant and asthma. The patient was allergic to Sulfa drugs, ramipril, peanut and shellfish. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date, levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date, multivitamins/D2 and fish oil received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccine within four weeks prior to vaccination. On 24March2021, the patient experienced watery itching eyes and frontal headache which had started after 5 days. Therapeutic measures were taken as result of watery and itchy eyes that included treatment with over the counter (OTC) eye drops. The clinical outcome of watery itching eyes and frontal headache was not recovered.   No follow up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Hypokinesia, Musculoskeletal chest pain, Musculoskeletal pain
Clinical narrative: Severe lower back pain within 2 hoursof second shot; couldn't walk, sit, stand orlie down; pain into buttocks; pain into ribs; This is a spontaneous report from a contactable consumer, the patient. A 68-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: ER8727), via unspecified route of administration in Right arm on 20Mar2021 at 10:00, (age at vaccination 68 years) as a single dose for COVID-19 immunisation. Medical history included degenerative disc disease and heart disease. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), naproxen (MANUFACTURER UNKNOWN). Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 20Mar2021 at 12:00 patient experienced Severe lower back pain after second shot. Within 4 hours, pain was so bad couldn't walk, sit, stand or lie down. Ice and heat did not help. Next morning pain into buttocks and ribs. Lasted for 48 hours. Ibuprofen was taken as therapeutic measure for the events lower back pain, pain into buttocks and ribs which did not help. The clinical outcome of the events lower back pain, pain into buttocks and ribs were resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: Anaxiety; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the left arm on 24Feb2021 at 14:00 (at the age of 69-year-old), as an single dose for COVID-19 immunisation. Medical history included anxiety. Concomitant medications included venlafaxine hydrochloride(MANUFACTURER UNKNOWN), clonazepam(MANUFACTURER UNKNOWN); all from unknown date for unspecified indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown), via an unspecified route of administration in the left arm on 04Feb2021 at 15:30 (at the age of 69-years-old), as a single dose for COVID-19 immunisation and Ceclor, and cipro on unknown date for unspecified indication and experienced a drug allergy and contrast dye on unknown dates and experienced contrast media allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 04Feb2021, the patient reported that she was led to 'vaccinator' desk for her 2nd COVID-19 vaccine, the vaccinator was complaining to her co-workers about how hot it was at her desk, that she had worked there for hours and had to move her desk. It was against a wall of windows on a warm, very sunny day the patient felt like a greenhouse! On the vaccinator desk, was a clear, not insulated case with 6-7 filled syringes of 2nd COVID-19 vaccines. The patient got her injection, and reported that whole experience projected a very lackadaisical attitude, and the vaccinator didn't even stamp her COVID-card. The patient didn't felt the relief that she imagined she would get when there was finally a COVID-19 vaccine. The patient was worried and filled with anxiety. The patient felt like her vaccine was spoiled because of how hot it was where her filled syringe sat-on top of the desk and this effected her mental health. The patient doesn't believe she was fully vaccinated and asked what can be done for her? A 3rd dose? as she didn't felt that she was fully vaccinated and still hiding in her apartment, and also stated Please contact this anxious 69 year old woman and this was unacceptable to her. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event anxiety was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Dizziness
Clinical narrative: Severe headache; Joint pain; Muscle pain; Fever of 103; Severe chills; Weakness; Still dizzy; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 25Mar2021 at 16:00 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not had allergy to any medications, food, or other products. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) and diazepam (VALIUM); both taken for unknown indication on an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Mar2021 at 06:00, the patient experienced severe headache, joint and muscle pain, weakness, fever of about 103 (unknown units) and severe chills for 24 hours. The patient still felt dizzy and weak 2 days later. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the reported events and included treatment with TYLENOL and ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of the events severe headache, joint and muscle pain, fever of about 103 and severe chills were resolving, while that of the event dizzy and weakness were unknown at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Severe headache; Joint pain; Muscle pain; Fever of 103; Severe chills; Weakness; Still dizzy; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 25Mar2021 at 16:00 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not had allergy to any medications, food, or other products. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) and diazepam (VALIUM); both taken for unknown indication on an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Mar2021 at 06:00, the patient experienced severe headache, joint and muscle pain, weakness, fever of about 103 (unknown units) and severe chills for 24 hours. The patient still felt dizzy and weak 2 days later. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the reported events and included treatment with TYLENOL and ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of the events severe headache, joint and muscle pain, fever of about 103 and severe chills were resolving, while that of the event dizzy and weakness were unknown at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Influenza like illness, Lethargy, Pain, Pyrexia
Clinical narrative: extreme lethargy on day 4; feel flu like; achey; low grade fever; overall feeling awful; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included Asthma, Meniere's Disease, Complex regional pain syndrome, POTS (Postural orthostatic tachycardia syndrome), penicillin allergy and Quinolones allergy. The patient reported that all her concomitant medications would not fit in space provided. The patient's past drug included LOVENOX and DEMEROL for unknown indications on unknown dates and experienced allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 09:00, on day 4, the patient experienced extreme lethargy, feel flu like, achey, low grade fever, major effort to get out of bed and overall feeling awful. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lethargy, flu like symptoms, ache, low grade fever and feels awful were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site discomfort
Clinical narrative: arm soreness; hard at the injection site.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Mar2021 at 15:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included hashimoto's thyroiditis. The patient was allergic to sulfa and erythromycin. Concomitant medications included thyroid (ARMOUR THYROID), fluoxetine (MANUFACTURER UNKNOWN), both taken for an unknown indication and received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 01:00, the patient had arm soreness that started one week after the injection. No rash, but also experienced hard at the injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of arm soreness and hard at the injection site was resolving at the time of this report.  No follow-up attempts are needed. Information about lot/ batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Hypokinesia
Clinical narrative: Bilateral knee pain/ pain while not moving; Difficulty walking, going up and downstairs; Inability to totally straighten or bend the knee; This is a spontaneous report from a contactable other health care professional, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9266), via an unspecified route of administration in the left arm on 18Feb2021 at 16:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and prenatal vitamins (MANUFACTURER UNKNOWN); both from unknown dates for unspecified indications. The patient previously received naproxen (MANUFACTURER UNKNOWN) on unknown date for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 21Feb2021, the patient experienced bilateral knee pain; lasting for five weeks, difficulty walking, going up and downstairs, pain while not moving, and inability to totally straighten or bend the knee. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with celecoxib. The clinical outcome of the events knee pain, difficulty in walking and movement reduced was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Limb discomfort, Malaise
Clinical narrative: heavy feeling in arms and legs.; Fatigue; headache,; general malaise; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 19Mar2021 at 14:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Mar2021 at 17:00, the patient experienced fatigue, headache, heavy feeling in arms and legs and general malaise. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events fatigue, headache, heavy feeling in arms and legs and general malaise. The clinical outcomes of the events fatigue, headache, heavy feeling in arms and legs and general malaise were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.